YU83686A - Process for obtaining new pyridine derivatives - Google Patents

Process for obtaining new pyridine derivatives

Info

Publication number
YU83686A
YU83686A YU00836/86A YU83686A YU83686A YU 83686 A YU83686 A YU 83686A YU 00836/86 A YU00836/86 A YU 00836/86A YU 83686 A YU83686 A YU 83686A YU 83686 A YU83686 A YU 83686A
Authority
YU
Yugoslavia
Prior art keywords
sub
lower alkyl
pyridine derivatives
obtaining new
compound
Prior art date
Application number
YU00836/86A
Other languages
English (en)
Inventor
T Mort
Y Ohsugi
Y Yamashita
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of YU83686A publication Critical patent/YU83686A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
YU00836/86A 1985-05-23 1986-05-20 Process for obtaining new pyridine derivatives YU83686A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11064285 1985-05-23

Publications (1)

Publication Number Publication Date
YU83686A true YU83686A (en) 1988-06-30

Family

ID=14540880

Family Applications (1)

Application Number Title Priority Date Filing Date
YU00836/86A YU83686A (en) 1985-05-23 1986-05-20 Process for obtaining new pyridine derivatives

Country Status (14)

Country Link
US (1) US4691018A (de)
EP (1) EP0203435B1 (de)
JP (1) JPS6253966A (de)
KR (1) KR860008980A (de)
CN (1) CN86103501A (de)
AT (1) ATE55992T1 (de)
AU (1) AU587251B2 (de)
CA (1) CA1240332A (de)
DE (1) DE3673693D1 (de)
ES (1) ES8707934A1 (de)
HU (1) HU195486B (de)
SU (1) SU1419517A3 (de)
YU (1) YU83686A (de)
ZA (1) ZA863706B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877795A (en) * 1987-01-30 1989-10-31 Kissei Pharmaceutical Co., Ltd. 4H-quinolizin-4-one compounds useful for the treatment of allergic bronchial asthma, allergic rhinitis atropic dermatitis and the like
DE3703963A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen
US4904657A (en) * 1987-09-24 1990-02-27 Kissei Pharmaceutical Co., Ltd. 4H-quinolizin-4-one compounds exhibiting therapeutic activities
JP2746832B2 (ja) * 1993-05-14 1998-05-06 大鵬薬品工業株式会社 眼局所抗アレルギー剤
TW264385B (de) * 1993-05-14 1995-12-01 Taiho Pharmaceutical Co Ltd
WO2010141883A1 (en) * 2009-06-04 2010-12-09 The Regents Of The University Of Colorado Compounds that modulate autoimmunity and methods of using the same
US9629848B2 (en) 2011-05-26 2017-04-25 The Regents Of The University Of Colorado, A Body Corporate Compounds that modulate autoimmunity and methods of using the same
KR102113891B1 (ko) 2012-08-30 2020-05-22 헌트레이 테크놀로지 리미티드 다층 환자 지지 커버 시트 시스템
US10363288B2 (en) 2015-01-14 2019-07-30 National Jewish Health Insulin mimotopes and methods of using the same
WO2017165508A1 (en) 2016-03-24 2017-09-28 Im Therapeutics Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3174885D1 (en) * 1981-02-03 1986-07-31 Ici Plc Process for the extraction of metal values and novel metal extractants
JPS58105920A (ja) * 1981-12-17 1983-06-24 Chugai Pharmaceut Co Ltd 抗癌剤
JPS58159465A (ja) * 1982-03-17 1983-09-21 Chugai Pharmaceut Co Ltd ピリジン誘導体

Also Published As

Publication number Publication date
ZA863706B (en) 1987-01-28
EP0203435A3 (en) 1988-01-07
DE3673693D1 (de) 1990-10-04
HU195486B (en) 1988-05-30
ES555240A0 (es) 1987-09-01
KR860008980A (ko) 1986-12-19
JPH0225906B2 (de) 1990-06-06
AU587251B2 (en) 1989-08-10
US4691018A (en) 1987-09-01
ES8707934A1 (es) 1987-09-01
EP0203435A2 (de) 1986-12-03
JPS6253966A (ja) 1987-03-09
HUT41735A (en) 1987-05-28
ATE55992T1 (de) 1990-09-15
CN86103501A (zh) 1987-01-21
AU5726786A (en) 1986-11-27
CA1240332A (en) 1988-08-09
SU1419517A3 (ru) 1988-08-23
EP0203435B1 (de) 1990-08-29

Similar Documents

Publication Publication Date Title
HUT47110A (en) Process for producing pyrazolopyridine derivatives
HU885889D0 (en) Process for the production of azaspirane derivatives
HUT49612A (en) Process for producing new 3-alkenyl-1-azabicyclo/3.2.0/ hept-2-ene-2-carboxylic acid derivatives and pharmaceutical compositions comprising same
YU83686A (en) Process for obtaining new pyridine derivatives
DE3564566D1 (en) Quinone derivatives, method and use of preparing same, and pharmaceutical composition
IL104773A0 (en) Naphthalene derivatives,their preparation and pharmaceutical compositions containing them
GR3018387T3 (en) Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them.
AU581052B2 (en) Preparation process of (6R)-tetrahydro-L-biopterin
AU589427B2 (en) Pyridonecarboxylic acid derivatives and process for their preparation
ES8703150A1 (es) Metodo de preparar derivados de b-carbolin-3-oxadiazolilo
ES8704445A1 (es) Procedimiento de preparar derivados aminicos
EP0393494A3 (de) Gallensäure-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen daraus
NO920614D0 (no) Forbindelse med antitumorvirkning og fremstilling derav
EP0132764A3 (en) New compounds derived from diphenyl-methylene-ethylamine
NO160297C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oksoazetidinderivater
ES8606330A1 (es) Procedimiento para preparar derivados de acidos quinolincar-boxilicos
ES8603184A1 (es) Metodo de preparar un derivado de acido b-carbolin-3-carbo- xilico
NO864635D0 (no) Nye krystallinske salter av aryloksyfenolaminer og deres fremstilling.
EP0348527A4 (en) Antiallergic eye drop
ES8705439A1 (es) Procedimiento para preparar derivados de pirazol-(1,5-a)piridina
AU655869B2 (en) An amphoteric tricyclic compound
ES8707537A1 (es) Un metodo para preparar derivados de acido 2-amino-5-oxo-5h-1 benzopirano 2,3-b piridin-3-carboxilico
EP0367671A3 (de) Beta-D-phenylthioxyloside, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
NO164170C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzhydryl-4-cinnamyl-piperazinderivater.
FR2583756B1 (fr) Procede de preparation des derives de la 2-halo-nicergoline et leurs sels d'addition avec des acides ainsi que des 2-halonicergolines nouvelles, compositions comportant des 2-halonicergolines et procede de preparation